Article Dans Une Revue Chemosphere Année : 2024

Heterogeneous catalysts for electro-Fenton degradation of cytostatic drug cytarabine

Résumé

In the present work, a reduced graphene oxide (rGO) modified-Fe 3 O 4 doped bifunctional carbon felt cathode (rGO-Fe 3 O 4 /CF) that is capable of generating and converting H 2 O 2 into hydroxyl radicals ( • OH) on-site was fabricated, thus removing the need for an external catalyst. In addition, an rGO-modified cathode (rGO/CF) with high H 2 O 2 production efficiency and a heterogeneous Fenton catalyst (CNT-Fe 3 O 4 ) with magnetic properties were fabricated. The study examined the degradation and mineralization of the cytostatic drug cytarabine (CYT) using two HEF configurations: (i) a bifunctional cathode rGO-Fe 3 O 4 /CF and (ii) a combination of the rGO/CF cathode with CNT-Fe 3 O 4 catalyst. The effects of parameters such as catalyst concentration, initial pH, and applied current were studied. HPLC and ion chromatography analyses were used to identify carboxylic acids and inorganic end-products, respectively. The results show that 0.1 mM CYT was completely degraded within 18 min at an applied current of 300 mA in the HEF system with the rGO-Fe 3 O 4 /CF bifunctional cathode. Total organic carbon (TOC) analysis revealed that the bifunctional cathode system achieved 98.2% mineralization of CYT after 4 h of treatment at 300 mA. Using the rGO/CF cathode and CNT-Fe 3 O 4 catalyst cell, total degradation of 0.1 mM.

Fichier principal
Vignette du fichier
1-s2.0-S0045653524027991-main_HAL.pdf (1.4 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-05377839 , version 1 (22-11-2025)

Licence

Identifiants

Citer

Şule Camcıoğlu, Baran Özyurt, Nihal Oturan, David Portehault, Clément Trellu, et al.. Heterogeneous catalysts for electro-Fenton degradation of cytostatic drug cytarabine. Chemosphere, 2024, 370, pp.143892. ⟨10.1016/j.chemosphere.2024.143892⟩. ⟨hal-05377839⟩
283 Consultations
145 Téléchargements

Altmetric

Partager

  • More